Clinical Trials Related to D-cycloserine

Related studies linked through entity extraction aliases.

Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder

Status: NOT_YET_RECRUITING
Phase: PHASE1/PHASE2

D-Cycloserine for Serine Palmitoyltransferase Inhibition

Status: COMPLETED
Phase: PHASE4

iTBS+D-Cycloserine for Youth Suicide

Status: RECRUITING
Phase: PHASE2

Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine

Status: COMPLETED
Phase: PHASE2

D-Cycloserine+iTBS PK Study

Status: COMPLETED
Phase: PHASE1

D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

iTBS-DCS in Fibromyalgia

Status: TERMINATED
Phase: PHASE2

iTBS-DCS in Obsessive Compulsive Disorder

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Pain, Learning, and Nocebo

Status: COMPLETED
Phase: NA

D-cycloserine Augmented Treatment for Youth With Tic Disorders

Status: WITHDRAWN
Phase: EARLY_PHASE1

Multimodal Cue Exposure Therapy for Smoking Cessation

Status: WITHDRAWN
Phase: PHASE2

The Effect of D-cycloserine on Emotional Processing

Status: COMPLETED
Phase: NA

Adjunctive D-Cycloserine in Major Depressive Disorder

Status: COMPLETED
Phase: PHASE2

AIH for Spinal Cord Repair

Status: TERMINATED
Phase: EARLY_PHASE1

D-cycloserine for the Treatment of Chronic, Refractory Low Back Pain

Status: TERMINATED
Phase: PHASE2

Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD

Status: WITHDRAWN
Phase: PHASE2/PHASE3

Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression

Status: COMPLETED
Phase: NA

D-cycloserine: A Novel Treatment for Gulf War Illness (GWDCS)

Status: UNKNOWN
Phase: PHASE2

D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression

Status: UNKNOWN
Phase: PHASE4

Glutamate, Learning, and Working Memory

Status: COMPLETED
Phase: PHASE1